Answers are grounded in this paper and cite their sources.
Nicotine-1′-N-oxide is reduced to nicotine in the lower gastro-intestinal tract in man after oral administration.2. No reduction or metabolism in vivo occurred by other routes after administration of the N-oxide by intravenous injection.3. Rapid absorption of nicotine and nicotine-1′-N-oxide occurred from the upper gastro-intestinal tract but absorption of N-oxide was incomplete.4. The hepatic first-pass phenomenon shown by nicotine was dependent upon the site of absorption in the gastro-intestinal tract.5. No apparent lipid solubility of nicotine-1′-N-oxide could be demonstrated by the buccal absorption test.
No takes yet. Share an insight, caveat, or question.
Jenner et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: